Loading... Please wait...

CRISPR Therapeutics AG (CRSP) Financials

Currency in USD Disclaimer
$53.10 -$0.8 (-1.48%)
$52.31
$53.69
$37.55
$91.1
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $370.00 M $436,000.00 $913.08 M $543,000.00 $289.59 M $3.12 M $41.00 M $5.16 M $247,000.00 $0.00
Cost of Revenue $130.25 M $110.25 M $17.95 M $269.41 M $179.36 M $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $239.75 M -$109.81 M $895.13 M -$268.86 M $110.23 M $3.12 M $41.00 M $5.16 M $247,000.00 $0.00
Gross Profit Ratio 0.65 -251.87 0.98 -495.15 0.38 1 1 1 1 0
Research and Development Expenses $387.33 M $461.65 M $438.63 M $266.95 M $179.36 M $113.77 M $69.80 M $42.24 M $12.57 M $1.51 M
General & Administrative Expenses $76.16 M $102.46 M $102.80 M $88.21 M $63.49 M $48.29 M $35.85 M $31.06 M $13.40 M $5.11 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $76.16 M $102.46 M $102.80 M $88.21 M $63.49 M $48.29 M $35.85 M $31.06 M $13.40 M $5.11 M
Other Expenses $71.82 M -$762,000.00 -$1.88 M -$176,000.00 $20.57 M -$5.49 M -$197,000.00 $78.51 M $16,000.00 -$236,000.00
Operating Expenses $462.29 M $563.35 M $539.55 M $354.98 M $242.85 M $162.07 M $105.65 M $73.29 M $25.98 M $6.63 M
Cost And Expenses $592.54 M $673.60 M $539.55 M $354.98 M $242.85 M $162.07 M $105.65 M $73.29 M $25.98 M $6.63 M
Interest Income $0.00 $22.66 M $0.00 $0.00 $10.03 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 -$46.83 M $0.00 $0.00 $0.00 $0.00 $0.00 $8.05 M $108,000.00 $0.00
Depreciation & Amortization $19.84 M $24.17 M $17.95 M $9.18 M $4.73 M $3.52 M $3.02 M $925,000.00 $127,000.00 $38,000.00
EBITDA -$202.70 M -$673.16 M $373.53 M -$345.25 M $46.74 M -$158.94 M -$61.62 M -$25.23 M -$25.59 M -$6.83 M
EBITDA Ratio -0.55 -1543.95 0.41 -635.82 0.16 -50.88 -1.5 -4.88 -103.59 0
Operating Income -$222.54 M -$673.16 M $373.53 M -$354.44 M $46.74 M -$158.94 M -$64.65 M -$68.13 M -$25.73 M -$6.63 M
Operating Income Ratio -0.6 -1543.95 0.41 -652.73 0.16 -50.88 -1.58 -13.19 -104.17 0
Total Other Income/Expenses Net $71.82 M $22.66 M $6.00 M $6.38 M $20.57 M -$5.49 M -$1.96 M $53.46 M $16,000.00 -$236,000.00
Income Before Tax -$150.72 M -$650.50 M $379.53 M -$348.06 M $67.31 M -$164.43 M -$66.61 M -$22.72 M -$25.82 M -$6.86 M
Income Before Tax Ratio -0.41 -1491.97 0.42 -640.99 0.23 -52.63 -1.62 -4.4 -104.54 0
Income Tax Expense $2.89 M -$325,000.00 $1.87 M $809,000.00 $448,000.00 $553,000.00 $1.75 M $484,000.00 $7,000.00 -$63,000.00
Net Income -$153.61 M -$650.18 M $377.66 M -$348.87 M $66.86 M -$164.98 M -$68.36 M -$23.20 M -$25.83 M -$6.80 M
Net Income Ratio -0.42 -1491.23 0.41 -642.48 0.23 -52.81 -1.67 -4.49 -104.57 0
EPS -1.94 -8.36 4.97 -5.29 1.23 -3.44 -1.71 -1.89 -0.88 -0.23
EPS Diluted -1.94 -8.36 4.7 -5.29 1.17 -3.44 -1.71 -1.89 -0.88 -0.23
Weighted Average Shares Out $79.22 M $77.75 M $75.95 M $65.95 M $54.39 M $47.96 M $39.97 M $12.26 M $29.30 M $29.30 M
Weighted Average Shares Out Diluted $79.22 M $77.75 M $80.39 M $65.95 M $56.93 M $47.96 M $40.06 M $12.26 M $29.30 M $29.30 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.